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ABBREVIATIONS 
 
ABC  - Aspiration Biopsy Cytology 
Acc  - Accuracy 
Ca  - Carcinoma  
CT  - Computed Tomography  
DNA   -  Deoxyribonucleic acid  
EM  - Electron Microscopy 
FNAC  -  Fine Needle Aspiration Cytology 
HPE  - Histo Pathological Examination 
MHZ  - Mega Hertz  
MRM  - Modified Radical Mastectomy 
N/C  - Nucleo Cutoplasmic ratio 
®   - Right 
(L)  - Left 
Sen  - Sensitivity 
Spe  - Specificity 
TCNB - Trucut Needle Biopsy  
USG  - Ultra sonogram 
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INTRODUCTION 
 
A lump in the breast whether benign or malignant results in 
anxiety for the patient and her family and the surgeon.  Histological 
tissue diagnosis is a universly accepted means of definitive diagnosis. 
Fine Needle Aspiration Cytology (FNAC) is gaining a wide 
acceptance as it gives a rapid diagnosis and can be carried out in out 
patient services. 
The trucut needle is a very handy instrument and it is almost 
replacing the incision or excision biopsy in the breast lump, as it can 
be carried out in the out patient services with minimal trauma.  
In this study   65 patients having breast lumps, were subjected 
to FNAC and Trucut Needle Biopsy as out patients and followed by 
operative treatment with a histological diagnosis, which were 
compared with tissue diagnosis (HPE). 
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REVIEW OF LITERATURE 
The clinical tissue cytology or non exfoliative cytology defined 
by Banforth in 1966 as follows.  “The examination of cells obtained 
by needle or drill biopsy in solid organs or tissue masses or from cut 
surface of such material freshly removed by surgical biopsy”. 
The present day definition as given by S.Kline is that  
“Fine needle aspiration cytology is the study of cells obtained 
by small gauge Needle generally with vacuum system provided by an 
air tight syringe”.   
Initially clinical evidence was preferred to biopsy.  If a lump 
ulcerated, it was cancerous.  In 1801, Adams2 observation on the used 
excision biopsy and macroscopy.  Both Paget31 and Erichsen13 were 
pioneer in tumour microscopy and published cytological illustration. 
The need for biopsy was recognized and emphasized by Laurence26 in 
1855 stating the instance where a breast was amputated for a supposed 
tumour which turned out after the operation to be only a chronic 
abscess. 
The necessity for the histological confirmation of the diagnosis 
before contemplating complex and often distinguishing or mutilating 
surgery cannot be over emphasized.  Thus developed surgery cannot 
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be over emphasized.  Thus developed the preoperative diagnostic 
procedures like frozen section and imprint smear cytology, or 
preoperative biopsy which should be simple, not distinguishing and 
carried out in the out patient department.  The technique of 
“TRUCUT” Needle biopsy and fine needle aspiration cytology 
followed. 
Investigation of a tumour by means of a needle was carried out 
in St.Bartholomew’s Hospital in 1833 for a case of abscess of the liver 
with Hydatid cyst.  The patient improved after this.  Needle biopsy 
became established method of diagnosing a collection of pus. 
Needle biopsy was first recorded by KUN25 in 1841 and was 
adopted by others. 
Erichsen in 1853 described as exploring needle to withdraw 
cells from a tumour for microscopy.  It is uncertain whether a syringe 
was added for suction, but substantiated Needle aspiration biopsy was 
introduced for the parasitological study of lymph nodes early this 
century. 
Menetrice in 1886 first used an aspiration needle to obtain 
tissue from a carcinoma of the lung and described the microscopic 
appearance of the specimen.  
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Mard in 1912 and Guthrie in 1921 used fine needle aspiration 
cytology to examine enlarged lymph nodes in cases of reticulosis.  
Subsequent exponents of this technique were martin and Ellis at 
Memorial Hospital in New York, who in 1926 began examination of a 
series of palpable malignant lesions, published the first series 
involving aspiration of a wide variety of Neoplasms consisting of 65 
malignancies including 6 breast cancers.  Three years later in 1933, 
Stewart reported the expanded experience in the same institution, 
which then included 2500 malignancies, with 500 breast cancers.  
Steward described in detail the pathological interpretation of the 
material obtained by aspiration.  Material was placed on a slide and 
smeared out and he suggested that the pathologist might obtain 
experience by smearing fragments from tumours obtained at operation 
or autopsy. 
Ferguson (1930) described the technique in prostate tumour ; 
Coley, sharp and Ellis (1931) in bone tumours, Forster (1931) in CNS 
tumours ; sharp in primary carcinoma of lung and Klinger and Burch 
(1932) as aspiration technique for endometrial tumours.  Graver and 
Binkley (1939) revived the literature in aspiration biopsy and gave the 
results of a large series of lung biopsies. 
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Despite the diagnostic success in these large series, there appear 
to be very little interest in these procedure during the ensuring 25 
years.  Attention was paid on trucut and drill biopsies.  In 1938, 
Silverman described a device to trap, within the needle, a core which 
was suitable for histological section.  This was variously modified and 
other devices developed for cutting off the end of the core retaining it.  
Attempts were then made to improve the cutting edge and teeth and 
bevels various angles were added to the needle.  Thus there developed 
method of drilling aimed at boring out a core of tissue rather than 
aspirating a few loose cells.  Initially these needles were rotated by 
hand.  But in 1934 and again in 1935 Kirschner described a hollow 
drill which was rotated by an electric motor through a flexible device. 
The technique of FNAC was revived in 1950’s by 
Scandinavians and its application in the diagnosis of palpable breast 
masses has become increasingly popular in recent years.  The original 
authors used an 18 gauge needle with air dried smear, and required 
local anesthesia.  The Scandinavians introduced the concept of fine 
needle aspiration with a 23 gauge needle improved cytology fixation 
and staining technique, and no need for local anesthesia.  This 
procedure was popularized in Scandinavia in 1968 for the diagnosis of 
breast masses.  It has only been in recent years the technique gained 
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acceptance in the United States.  These has resulted from a 
combination of factors including the ease, rapidity, accuracy and lack 
of morbidity of the technique, the increase in desire of female patient 
to have the opportunity to adjust to a define malignant diagnosis 
before consenting to surgery and relatively low cost of the procedure 
compared to the open biopsy. 
The fine needle biopsy was defined by Godwin17.  Annals of 
Newyork academy of Sciences, 63, 1348) as the withdrawal of cells or 
small bits of tissue through a needle by means of a negative pressure. 
Exfoliative cytology defers in aim from aspiration cytology in 
that the former used primarily to detect a cancer clinically not yet 
apparent, while the latter is used to determine the microscopic nature 
of a clinically detectable tumour.  In this respect aspiration cytology is 
similar to histological examination of a surgical biopsy.  The term 
ABC – Aspiration Biopsy Cytology was used by Zajicek and 
Lawhagel as a synonym of FNAB or FNAC.  It (ABC) was chosen to 
clearly distinguish aspiration from exfoliative cytology and to 
emphasize its simplicity24. 
Now at the Radium Hemet in Stockholm, about 12,000 
aspiration are performed every year.  Other centers using these 
technique on a large scale are the Herzen institute of Oncology in 
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Moscow, the curie foundation in Paris and the Memorial Hospital in 
Newyork. 
In India10 these useful cost effective simple investigation has yet 
to gain popularity though during the last 25 years or so reports have 
tricked in on these subject, claiming the cells equivalent to those of 
western counterpart.  
Trott and Raadal in 1979 summarized the relative merits of 
FNAC compared to excision biopsy histopathology as given in the 
table. 
Table No. 1 
S. No. Diagnosis FNAC Histopathology
1 Anaesthesia  No Yes 
2 Length of procedure <5 min 75 min 
3 Report available Few hrs 1 – 2 days 
4 False positive Rare None  
5 False negative Some Few 
6 Cost Low High 
7 Specimen abstained As out patient / 
bedside 
In operating 
theatre 
8 Trauma  Little if any Yes 
9 Stay in hospital No Yes 
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RECENT ADVANCES28 
 With advent of imaging with radiography, ultrasonography and 
CT scanning, its usage has become still more wider in clinical 
practice. 
GUIDED FNAC 
USG GUIDED 
 Aids in accurate localization of breast lumps.  They also to 
differentiate between solids and cyst lumps   Lumps upto 2 mm can be 
biopsied with the help of USG.  7 MHZ probe is used for better 
discrimination.  Cyst can be aspirated fully and followed up to direct 
any recurrence. 
MAMMOGRAM GUIDED 
 Mammography taken in two direction can be used to localize 
non-palpable breast lumps and subject them to FNAC. 
STERIOTACTIC GUIDED 
 This is mainly useful in core needle biopsies and erosion 
biopsies. 
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AIMS AND OBJECTIVES 
 
 Out patient assessment of breast lumps 
 To compare the results of FNAC and trucut needle biopsy in 
breast lumps with histopathological examination.  
 To assess the incidence of average age. 
 To compare the incidence – married Vs unmarried.  
 To know the average size of breast lump. 
 To evaluate the peak incidence of site of breast lump. 
 To compare the incidence – premenopausal Vs postmenopausal. 
 To know the average duration of the breast lump. 
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PATHOLOGY OF BREAST 
 
BENIGN BREAST LUMPS35 
1. Fibroadenosis (Fibrocystic Disease)  
 It occurs from adolescence through senescence, but particularly 
during menarche.  It generally produces a lumpy feeling rather than a 
mass per se.  It is due to an Aberrations of Normal Development and 
Involution (ANDI).  Areas sectioned with a knife may be white or 
yellow but never present the grey tones of carcinoma. 
MICROSCOPICAL FEATURES  
a. Microcyst Formation – are long standing and vary much in 
size.  They contain dark – mucoid material. 
b. Adenosis – an overall increase in Acinal material 
c. Fibrosis – swelling of interstitial tissues and round cell 
infiltration 
d. Epitheliosis – hyperplasia of epithetium in the lining of acini 
e. Papillomatosis – small branching papillomas inside the cysts 
or small ducts. 
f. Calcification – coarse irregular pattern chemically composed 
of calcium phosphate or calcium oxalate 
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Fibroadenosis with Epithelial hyperplasia may lead to a malignant 
lesion.  In a large breast the differential diagnosis between 
fibroadenosis and carcinoma in the very early sage is difficult, when 
an ill-defined lump is deeply situated. 
2. MASTITIS3  
 Acute mastitis due to bacterial infection most commonly occurs 
within the first few weeks of lactation.  Infection usually results from 
staphylococci or streptococci entering the breast through abraded or 
lacerated nipple surfaces or by way of lactiferous ducts as they enter 
the nipple.  Lymphatic involvement results in either cellulitis or frank 
abscess formation. 
 Streptococcal infection tend to produce a diffuse cellulitis often 
with systemic toxic manifestations.  Abscess formation is more 
common in staphylococcal aureus infections.  Usual cause of chronic 
mastitis with abscess formation is tuberculosis, which is secondary to 
pulmonary or chest wall diseases.  Chronic mastitis when associated 
with a thick fibrous wall cannot be differentiated clinically from a 
carcinoma. 
3. FAT NECROSIS  
 It occurs following trauma either direct or indirect (e.g.) 
contraction of pectoralis major.  In recent cases a superficial brushing 
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suggests the cause.  The disease can situated carcinoma because of 
skin retraction.  On cut sections, a chalky white area of necrotic fat is 
found resembling necrosis seen in subsiding acute pancreatitis. 
4. DUCT PAPILLOMA  
 The papilloma projects in to a dilated duct, usually in the 
vicinity of the nipple.  Initially resembling a small raspberry but later 
gets a smoother outline.  Finally, distending the ducts it becomes a 
solid, compact mass.  It is the cause of a bright red, a dark blood 
stained or rarely a serosanguinous discharge per nipple.  A cystic mass 
may be palpable behind the nipple. 
5. FIBROADENOMA14  
 It is a slow growing benign Neoplasm with a predilection for 
the young adult, majority of cases before the age of 63 years.  It may 
be caused by Hormonal Imbalance, when the concentration of 
oestrogen is high they tend to grow faster (i.e.) during Adolescence 
and pregnancy.  Palpation reveals a dominant, discrete, mobile 
rubbery mass, usually no greater than 3 cm in diameter.  The cut 
surface is solid, grayish white, and belonging, with a whorl like 
pattern and slit like spaces.  Necrosis, it may be hyalinised or calcified 
(Ref. Line. T.S.1981). 
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 Although mixed forms occurs, the encapsulated, predominantly 
stromal tumour is of two varieties on histologic section.  The 
intracanalicular, fibroadenoma with broad, polypoid, loose branches of 
connective tissue lined by cuboidal ductal cells, emerges from and 
obliterates the duct.  The pericanalicular, fibroadenoma encircles the 
ducts with dense, concentric mesenchyma. 
6. CYSTOSARCOMA PHYLLOIDES 
   This is a rare variant of fibroadenoma often referred to as a 
giant fibroadenoma.  When it was first described by Muller (1838), it 
received its name because the tumour contained large cysts and was 
fleshy, a connotation for the term “Sarcoma” at that time.  Large 
surface clefts were thought to resemble leaves in a book, this accounts 
for the choice of the term “PHYLOON” most of these tumours are 
benign (Leaf).  But a few develop true sarcomatous potential. 
7. GYNAECOMASTIA 
 It is the enlargement, probably endocrine related, of the male 
breast and it most common in adolescent and elderly persons.  
Although there is often generalized hypertrophy, there may be a 
discrete tumour adjacent to the nipple.  Microscopic examination 
reveals ductal hyperplasia and dilatation, loose stromal proliferation 
and an inflammatory infiltrate. 
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8. GRANULAR CELL MYOBLASTOMA  
 The origin of this tumour is obscure, perhaps in smooth muscle 
or histocytic or neurogenic tissue.  Clinically, both macroscopically 
and microscopically, the tumour may appear poorly demarcated and 
the overlying skin may show atrophy and retraction.  The non-
capsulated tumour nests may be diffused dispersed in sheets or small 
groups.  However, the cells, with fine acidophilic granule are 
morphologically benign. 
9. MESENCHYMAL BENIGN NEOPLASMS  
 Rarely lipoma, Epidermal inclusion and Sebaceous cyst,  
Fibroma, Keloid etc are like the same as in any other parts of body.  
Their general pathological account are beyond the scope of this study.   
MALIGNANT NEOPLASMS35 
CLASSIFICATION 
 Foot and Stewart have stressed the fact that cancer of the breast 
can arise from either, the lobules, the ducts or the nipple, with the 
tumour arising from ductal epithelium in the majority of cases. 
I. Carcinoma of nipple – Paget’s disease 
II. Carcinoma of the ducts 
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A. Non infiltrating 
1. Papillary 
2. Comedo 
B. Infiltrating 
1. Papillary 
2. Comedo 
3. Adeno carcinoma with fibrosis (scirrhous carcinoma) 
4. Medullary carcinoma with lymphoid infiltration 
III. carcinoma of lobules 
A. Non-infiltrating 
B. Infiltrating 
IV. Others 
1. Mucinous carcinoma 
2. Sweet gland carcinoma 
3. Inflammatory carcinoma 
NON INFILTRATING PAPILLARY CARCINOMA 
 It is a type of ductal carcinoma insitu and it is a rare variety, 
arise from large, medium or small ducts.  The papillary formation is 
evident but a typical and distribution from benign – papillomatosis of 
cystic hyperplastia may be difficult.  The most valuable feature is loss 
of normal cell polarity and arrangement. 
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NON INFILTRATING COMEDO CARCINOMA  
 It arises in the smaller or intermediate sized ducts.  The worm 
like casts of comedo can be expressed from cut surface.  The cells are 
more anaplastic than papillary carcinoma.  They completely occupy 
and distend the ducts. 
INFILTRATING ADENO CARCINOMA WITH FIBROSIS 
 This is the most common type of breast carcinoma accounting 
for about 70-75% of the total cases, commonly known as scirrhous 
adenocarcinoma.  The tumour cells possess infiltrative properties and 
have the ability to Evoke fibrous tissue profileration.  Hence the 
tumour becomes adherent to the surrounding tissues and the skin. 
 It presents an unyielding induration to the knife and gives a 
sensation of cutting through an unripe pear.  The cut surface is 
depressed owing to the pull of fibrous tissue. 
 There is a great variation microscopically.  Most frequently the 
cells are spheroidal and arranged in small clumps and columns or in a 
single file.  In other cases the picture is more cellular with cells being 
hyperchromatic and pleomorphic. Sometimes an almost acellular field 
with the few cells compressed and narrowed by dense collagenous 
stroma is seen. 
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MEDULLARY CARCINOMAS WITH LYMPHOID 
INFILTRATION 
 It is bulky, soft and rounded.  Haemorrhage and cyst formation 
are common.  The cells lack the invasive biological activity of the 
scirrhous type, so the tumour is not adherent to the skin. 
 Microscopically the cells which are arranged in large masses 
have abundant cytoplasm with large vesicular nuclei and many 
mitoses.  Infiltration with lymphocytes is a highly characteristic 
feature. 
LOBULAR CARCINOMA36  
 In this type the cells appear to arise with in the lobule itself.  It 
may be non infiltrating or infiltrating. 
The non infiltrating type is carcinoma insitu.  It cannot be 
recognized in the gross and is an incidental finding.  Microscopically, 
it consists of large lobules confined to a limited area.  The acinar cells 
are piled up and are arranged in an irregular fashion.  The appearance 
of solid masses in enlarged lobules is characteristic.  The infiltrating 
type is indistinguishable in the gross firm scirrhous carcinoma.  
Microscopically, it can be distinguished from that variety only by 
finding examples of pre-invasive pattern in the neighbourhood.  Both 
forms of lobular carcinoma are uncommon. 
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PAGET’S DISEASE  
It is found in women 40-60 years of age and commences as an 
eruption of the nipple and areola.  Following a variable period of 2-10 
years a mass becomes palpable beneath the areola.  The eczematous 
area is bright red and inflamed with a moist and weeping or a dry, 
scaly surface. 
The microscopic picture  presents, three features : 
1. Epidermal hypertrophy 
2. Paget’s cells 
3. Sub-epidermal round cell 
Epidermal hypertrophy is a constant feature before ulceration 
occurs, papillae being increased in depth and width. 
 Pagets cells are large clear vacuolated cells with  small pyknotic 
nuclei.  They look like clear spaces punched out of the epidermis.  The 
superficial part of the dermis shows round cell and plasma cell 
infiltration.  Proliferation changes in the epithelium of the breast are 
also seen. 
MUCINOUS CARCINOMA  
 This tumour has gelatinous materials within it and has sharply 
delineated margins.  Mucinous carcinomas are usually large, bulky 
tumour, reddish brown or purplish in colour with slimy material 
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present on the cut surface.  The cells have acquired the ability to form 
mucin.  Microscopically mucin filled cells surrounded cyst like 
spaces.  Some of the tumours show clumps of tumour cells in a sea of 
mucoid material.  The cells are often well differentiated and may even 
have a signet ring appearance. 
SWEAT GLAND CARCINOMA 
 The mammary and sweat glands have a common origin.  
Structures which are apparently sweat gland tubules occur in the 
normal breast and anastomose with the lacteal ducts.  They are 
distinguished by eosinophilia of the cytoplasm and an inner layer of 
high columnar cells.  Certain carcinoma of the breast especially 
situated at the periphery may show these characteristics and hare 
called sweat gland carcinoma.  Their behaviour is the same as that of 
ordinary breast carcinoma. 
ACUTE INFLAMMATORY CARCINOMA  
 The term inflammatory carcinoma reflects the appearance of the 
breast : hyperaemia, tenderness, skin retraction and oedema producing 
the characteristic peau d’ orange.  Although usually diffuse, the 
malignancy may resemble a localised abcess.    Histologic section 
reveals widespread carcinoma, often the inflammatory ductal variety 
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with nests of tumour in the dermal and epidermal lymphatics.  
Blockage of vessels may cause the cardinal signs of inflammation. 
MIXED DUCTAL AND LOBULAR CARCINOMA  
 This is a very rare carcinoma, it composed in part of a 
component with definite features of invasive ductal carcinoma and in 
part of a component with definite features of invasive lobular 
carcinoma do occur. 
This tumour has to be distinguished from tubular carcinoma and 
from the cases in which two separate neoplasms of different 
microscopic appearances are present in the same breast. 
METAPLASTIC CARCINOMA  
 Metaplastic carcinomas in a genetic term for breast carcinoma 
of ductal type in which the predominant component of the neoplasm 
has an appearance other than epithelial and glandular and more in 
keeping with another cell type. 
1. SARCOMATOID CARCINOMA 
(Carcinoma with sarcoma like stroma) 
 Grossly, it is well circumscribed.  Microscopically, the 
sarcomas like component may resemble malignant fibrous 
histiocytoma, chondrosarcoma, osteosarcoma, rhabdomycosarcoma, 
angiosarcoma (or) combination of them. 
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2. SPINDLE CELL CARCINOMA 
 The overt carcinomatous component of these tumours, entirely 
squamous.  The spindle cell component, which may be deceptively 
bland, forms abundant fibrocollagenous stroma with featured, myxoid, 
angioid and storiform patterns.  The appearance may closely simulate 
that of a fibro sarcoma or even fibromatosis. 
3. Carcinoma with osteoclast like giant cells 
4. Squamous cell Carcinoma 
5. Others 
  31
CYTOLOGICAL APPEARANCES IN 
MAMMARY DISEASE 
 
I. MALIGNANT NEOPLASMS35 
a) CARCINOMA 
Criteria for diagnosis 
1. The most important criterion is the cellularity.  Aspiration from 
carcinomas are usually very cellular. 
2. Due to loss of cohesiveness, cancers cells are frequently present 
in small groups and also as single cells. 
3. Overlapping of cells and crowding in seen 
4. Nuclei are pleomorphic.  Enlarged in size and of irregular 
shape.  Nucleoli are present. 
5. High nucleocytoplasmic (N/C) ratio 
6. Intranuclear variants are seen in some benign and malignant 
breast tumours, hence not of much use in diagnosis. 
7. Mitoses may or may not be seen and so it not a useful criterion 
8. Groups of carcinoma cells in fat indicates infiltration 
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         Cytological characteristics of benign and malignant aspirates are 
compared 
FNAC OF BREAST – SMEAR CHARACTERISTICS 
Table No. 2 
Cytological 
Findings 
Benign Malignant 
Pattern Epithelial cells in sheet and 
clusters, monolayered, 
regularly arranged, few 
single cells 
Epithelial cells in 
clusters of varying 
size, multi layered, 
irregularly arranged.  
Many single cells 
Single Cells Monomorphic oval, naked Polymorphous round 
with cytoplasm 
Nuclei Small, uniform Enlarged, 
pleomorphic 
Chromatin Evenly distributed, light Coarse, heavy 
Nucleoli Usually absent Present in moderate 
number of cells 
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Two most important criteria are cellularity and nuclear atypia.  To 
avoid over diagnosis which can lead to a mutilating surgery, 
conservative approach while giving positive report of carcinoma in 
essential.  No diagnosis of malignancy should be given if only one of 
the above mentioned criteria in identified. 
It is also important to remember that the impression of 
carcinoma should be recognized in several fields of the smears. When 
the smears are extremely cellular, but lack sufficient atypicality for a 
firm diagnosis of carcinoma.  It is advisable to ask for a biopsy.  In 
most of these cases, the lesion will be a well differentiated duct 
carcinoma.  Repeat aspiration will be of no further help in such a 
situation. 
TYPING OF BREAST CARCINOMA 
 Typing of the carcinoma may help the clinician in 
prognosticating the diseases and deciding the line of treatment.  Ortel 
and Galbum have come out with some criteria helpful in classifying 
different types of breast carcinoma. 
i) Medullary Carcinoma 
 It is soft of an aspiration.  The smears are cellular with bubbly 
back ground due to proteinaceous material and show varying 
proportion  of  lymphoid  cells  and carcinoma ells.  Nuclei of varying  
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sizes and shapes with prominent nucleoli are seen.  These may be 
naked or with scanty cytoplasms.  Few bizzare forms may also be 
seen.  Mitoses are often present. 
ii) Mucinous Carcinoma 
 Like medullary carcinoma, this type of carcinoma in also soft to 
aspirate.  Aspirated sample consists of abundant bluish pink mucoid 
material.  Smears are thick and show tight groups of cells.  Often 
nuclei are regular.  Metachromasia may be seen in Giemsa sainted 
smears.  A striking feature observed is the presence of many branching 
blood vessels running through the mucus pools. 
iii) Tubular Carcinoma 
 Cellular aspirates reveal groups of ductal cells with blunt 
branching and tubular lamina.  On low power these groups mimic 
fibroadenoma, but naked nuclei are not present.  Groups of epithelial 
cells with branching are not as complex as seen in fibroadenoma. 
iv) Adenoid cystic carcinoma 
 Large number of cells are seen in abundant pale pink mucoid 
background in which bright pink dense globules are seen.  Most of 
these globules are surrounded by cells with small, round regular 
nuclei. 
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v) Papillary carcinoma 
 Aspirate is usually haemorrhagic and thick.  The smears are 
cellular fragments of tissue with fibrovascular core and finger like 
projections are present.  Nuclei are usually enlarged but regular. 
vi) Lobular carcinoma 
 This type of carcinoma, like infiltrating duct types, is fibrous 
and gritty on aspiration.  Aspirates are not usually cellular.  Smears 
reveal small cells in a small groups in short chains (Indian files) or as 
scattered single cells.  Not much variation in nuclear characters and 
size is seen. 
vii) Malignant cystosarcoma phylloides 
 smears are similar to those from fibroadenoma.  Stromal 
fragments show cellularity and nuclear atypia.  Pleomorphism, 
hyperchromasia and frequent mitoses suggest a malignant neoplasm. 
II. BENIGN LESIONS 
a. Fibrocystic diseases 
 Aspirates are not cellular.  The material consists of metaplastic 
apocrine cells, benign ductal epithelial cells in fluid back ground and 
fragments of fibroadipose tissue.  In addition, few foamy macrophages 
and  inflammatory  cells  are  seen.   Aspirates  from  these  lesions are  
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often unsatisfactory.  Presence of apocrine cells are necessary for the 
diagnosis of fibrocystic disease.  
b. Fibroadenoma 
 Fibroadenoma can be readily diagnosed cytologically as usually 
these yield cellular aspirates.  Smears are rich in large tight sheets of 
benign ductal epithelial cells admixed with naked nuclei within the 
clumps and also scattered single epithelial clusters reveal blunt 
branching.  Stroma can be myxoid. 
c. Abscess 
 Aspirated material consists of thick yellowish pus.  Smears are 
thick and show numerous polymorphs, fibrin strands, foamy 
macrophages, cellular debris and occassional groups ductal epithelial 
cells.  Inflammatory atypia when present create diagnostic  problems.  
However, carcinoma in usually not associated with such marked acute 
inflammatory component. 
d. Fat necrosis 
 Numerous lipid laden macrophages and epithelial cells are seen 
in the back ground of acute and chronic inflammatory cells.  Fatty 
vacuoles of varying size are present.  Cytology atypia is often present. 
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MATERIALS AND METHODS 
  
Sixty five patients presenting to surgical out patient department 
of Coimbatore Medical College during 2005 - 2006 period, were 
subjected to Fine Needle Aspiration Cytology and Trucut Needle 
Biopsy.  All the patients underwent surgery depending upon the report 
of the two methods and finally all the reports of the techniques were 
matched with the histological report of the excised specimen. 
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A. TECHNIQUES OF FNAC 
 It need not be emphasized that the proper clinical examination 
of the patient is to be carried out in detail and the disease process must 
be localized and clearly defined.  Simpler investigation should be done 
routinely in every patient. 
 The case should be discussed with the pathologist before the 
FNAC23 is being one regarding the feasibility and the likely 
informative value of FNAC in the particular case concerned. 
PREPARATION FOR FNAC 
EQUIPMENTS REQUIRED 
1. 23 gauge 0.6 – 1 mm, external diameter disposable needles 2.5 
and 5 cm long. 
2. 10 – 20 mm disposable syringe with leur lock tip 
3. “CAMECO” syringe pistol 
4. Microscopic glass slide with frosted ends 
5. Fixative 
6. Alcohol sponges 
7. Sterile gauze pads 
8. Sterile containers 
9. others  
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NEEDLES 
 Standard disposable  25-22 gauge 25-50 mm long needles are 
suitable for  most superficial, palpable lesions. 
 Finest needles (25 gauge) are recommended for children and for 
sensitive areas like orbit and eyelids. 
Thicker needles offer no advantages instead cause more 
bleeding and can be blocked by plug of tissue and carry the risk of 
tumour implantation in the needle track. 
The 22 gauge, 90 mm disposable lumbar puncture needles with 
trocar are convenient for most deep lesions. 
If still longer needles are required, then a 22 gauge 150 – 200 
mm chible needle can be used.  Franzen instrumentation provides 
special long needles for biopsy of prostate and pelvic organs. 
Rotex II screw needle (0.8 mm, 145-205 mm size) is used for 
deep biopsy of lung, liver, kidney, lymphnodes etc.  This is 
particularly useful in fibrous lesions, soft tissue tumours and in richly 
vascular lesions. 
However the standard needles are less expensive, easier to use 
and give a satisfactory yield in majority of cases if the technique is 
correct. 
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Standard disposable plastic syringes of 10-20 ml are used.  It should 
be of good quality for strong rigid material and produce a good 
negative pressure. 
SYRINGE HOLDERS 
 The use of syringe holder is strongly recommended.  Leaving 
one hand free to immobilize and to feel the target lesion allows better 
precision in placing the needle.  Regularly used syringe holder is 
cameco syringe pistol (Cameco AB, Taby, Sweden) made to fit either 
10 mm or 20 ml syringe. 
SLIDES 
 They should be dry and free of grease, those with frosted ends 
are convenient for immediate labeling.  A 0.1 mm haemocytometer 
cover slip gives better control over pressure used in smearing.  Air 
dried slides are best transported in stainless steel carrier to avoid 
contamination and scratching. 
FIXATIVES 
 For wet fixation, 70-90% ethanol preferably in koplin jars (for 
spongy fixatives) is used.  Canroy’s fixative has the advantage of 
lysing RBCS.  Glutaraldehyde with 10% buffered formalin is used if 
tissue fragments are needed. 
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STERILE CONTAINERS  
 Those filled with physiological saline or Hank’s balanced salt 
solution is used to rinse the needles and syringes to obtain material for 
culture. 
OTHERS 
 Skin disinfectants, sterile dressing, local anaesthetic, watch 
glass.  Thrombin powder, pencil, tongue depressor and sterile blades. 
PREPARATION OF PATIENT 
 Clear explanation of the procedure to the patient will ensure the 
patients consent and better cooperation. 
Informed consent should be obtained.   
Selective positioning of the patient is must for particular 
anatomical areas. 
Preparation of local area with sterile swabs are done 
preliminarily.  Local anesthetics are applied only when required.  It is 
not always indicated but if given if facilitates multiple passes more 
acceptable by the patient. 
PROCEDURE 
INSERTION OF NEEDLE 
 Better control over needle is achieved by supporting the barrel 
of syringe by the forearm.  Vertical approaches tend to be less painful  
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and allows better appreciation of depth.  If needed, imaging techniques 
may be used to localize the lesion for favouring correct insertion of 
needle. 
ASPIRATION1 
 This mechanism has been explained well by THOMBSON.  
The function of the negative pressure used is not to tear cells from the 
tissue but to merely fix the tissue against the sharp clothing edge of 
the needle.  The softer tissues protruding over the edge are cut off and 
accumulate in the  lumen of the needle as it advances through the 
tissue  (eg) tumour cells, glandular and epithelial elements.  But the 
stroma is poorly represented in the aspirate. 
 For greater yield, the needle should be moved back to forth 
especially in fibrous lesion.  This is termed as Jackhammer method.  
Sometimes, multiple passes may be needed for obtaining satisfactory 
number of cells.  But in case of vascular tissues, it produces more 
blood in the sample.  Blood in the syringe means an unsatisfactory 
aspirate. 
 The ideal aspirate has high cell content in a small amount of 
fluid, a creamy consistency and remains within the lumen of needle. 
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 It is necessary to release the negative pressure before the needle 
is withdrawn.  This prevents the aspirate to get into the syringe or 
being contaminated with contents aspirated during withdrawal. 
NEEDLING WITHOUT ASPIRATION27 
 It was introduced by Zajdela in the principle that the capillary 
pressure of the fine needle is itself sufficient to keep the cells within 
the lumen.  Here the negative pressure and aspiration are not used.  
Simple insertion and back to forth movement is applied while 
simultaneously feeling the consistency of tissue concerned thereby 
improving precision, lesser admixture of blood cells, it cell yield is 
some what less but not significantly so. 
 A 25 gauge needle is preferably used this technique.  It can be 
used in all superficial lesions (except cystic and fibrotic ones) and 
deep lesions (when more blood aspirated by regular technique). 
After the procedure is over, application of gentle pressure over 
the biopsy site is important to minimize bruising and to decrease the 
chance of haematoma formation in case of highly vascular lesion. 
CAUSES FOR UNSATISFACTORY YIELD32 
1. Needle has missed the lesion tangentially. 
2. Central cystic, necrotic or haemorrhagic area devoid of 
diagnostic cells 
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3. Small malignant lesion adjacent to dominant benign mass 
4. Fibrosclerotic target tissue poor in cells 
5. Mislabeling or interchanging of specimen either during 
collection or in laboratory  
6. Deterioration of specimen because of delayed processing or 
poor fixation 
7. Imperfect staining 
8. Contamination 
9. Lack of an adequate history 
PREPARATION OF ASPIRATE 
DIRECT SMERING 
 An aspirate is said to be “Dry” if it consists of numerous cells 
suspended in a small amount of tissue fluid and has a creamy 
consistency and this is perfect one.  In contrast, a ‘wet’ aspirate is a 
one which consists of small number of cells suspended in fluid or 
blood.  A dry aspirate is best smeared with the flat of 0.4 mm.  
Coverslip exerting a light pressure to achieve a thin even spread, the 
firm pressure causes crush artifacts.  So it should not be too thin or too 
thick. 
A wet aspirate should be smeared in a “two step” method.  The 
first step is moving the coverslip or the smearing slide to the middle of 
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specimen slide, holding it at an obtuse angle which leave the fluid and 
makes the cells follow the smearing slide like buffy coat.  The second 
step is same as that described under dry aspirate smearing. 
The correct technique should be followed especially in air dried 
smear good fixation depends on rapid drying. 
If large amount of blood is aspirated it is expressed onto and 
spread over a watch glass before clothing and minimal particles are 
picked up for histological processing. 
If the sample is large enough, several slides can be prepared 
both air dried and wet fixed so that special staining can be carried out 
if required. 
FIXATION AND STAINING 
 We are using isopropyl alcohol as a fixative.  Fixation does not 
require more than a few minutes of thirty minutes to one hour is 
advisable for proper adhesion of the smear to slide.  Number of 
fixatives are used in cytology.  The common ones are modification of 
95% ethyl alcohol can be used on its own with satisfactory results but 
the addition of 3% glacial acetic acid increase the nucleoprotein fixing 
properties. 
This is the standard fixative and gives excellent nuclear and 
cytoplasmic morphology. 
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STAINING PROCEDURES 
 Smears can be stained by pappanicolaou or by standard 
hematoxylin and eosin methods.  The basic constituent of both stains 
is Harris hematoxylin.   
 Cytoplasms of cornified cells – reddish – pink.  Cytoplasm of 
non cornified cells green (deeper the younger cells, lighter in the 
mature cells). 
Nuclei are stained blue. 
SPECIAL STAINS 
1. PAS / Diastase or Alcian blue for mucin 
2. Prussian blue for iron 
3. Masson – Fontana for melanin 
4. Grimelius for argyrophilic granules 
5. Congo red for amyloid 
6. Gram / PAS / Gomori silver stain for microorganisms 
7. Ziehl – Neelson for AFB 
8. Special stains for pneumocystis, Nocardia or Actinomycetes. 
9. PAS for glycogen 
10. Oil red – O – for fat 
11. Fouchett’s reagent counter stained with Sirius red for bile 
pigments. 
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12. Formaldehyde induced fluorescence for amine, melanin 
precursors. 
Air dried smear are suitable for enzyme histochemistry (eg) 
Acid phosphatase in carcinoma prostate. 
PHASE CONTRAST MICROSCOPY 
 Phase contrast of unstained smears is an useful tool to check the 
quality and representatives of smears to be used for 
immunoperoxidase staining or for EM so that time and reagents are 
not wasted on unsatisfactory samples. 
ULTRASTRUCTURAL STUDIES 
Aspirate obtained by FNAC are also suitable for  
• Immuno cytochemistry 
• Enzyme cytochemistry 
• Electron microscopy 
• Flow cytometric quantitation of DNA 
COMPLICATIONS AND HAZARDS OF FNAC 
 FNAC is associated with relatively few complications.  Possible 
commonly encountered complications are as follows : 
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1. HAEMATOMAS 
 Bleeding from the puncture site and haematoma formation are 
the commonest complications of the procedure.  Firm pressure for 2-3 
minutes immediately after the procedure greatly reduces this problem. 
2. INFECTION 
 Introduction of infection is not a significant hazard in breast 
FNAC.  Transrectal aspiration in cases of acute prostatitis may result 
in bacteraemia. 
3. DISSEMINATION OF TUMOUR 
 Generally dissemination of malignant cells following FNAC is 
a theoretical possibility.  Local dissemination by seeding of malignant 
cells along the needle tract is a rare complication. 
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B. TECHNIQUE OF TRUCUT NEEDLE 
BIOPSY (TCNB) 
 
REQUIREMENT FOR TCNB9 
a. Needles 
 Disposable trucut needle 16 G or 18 G which can be used for 
about 5 to 6 cases (or) metal trucut needles which can be used for 
about 15 to 20 cases can be used.  In this study 18 gauge disposable 
trucut needle used. 
b. Syringe 
 2ce disposable syringe for local anaesthesia 
c. A local anaesthetic (2% xylocaine) cotton and spirits 
TECHNIQUE OF TCNB22 
 The palpable lesion is fixed with two heads of assistant.  The 
skin in cleaned and local anaesthetic is infiltrated.  The needle is 
inserted and as soon as the lump in reached, the needle is advanced.  
Once the inner needle is inside the mass the outer needle is pushed and 
whole trucut withdrawn.  The material inside the stillet is taken and 
sent for HPE. 
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CAUSES OF FAILURE 
(REF. GIBSON & SMITH 31, 1957) 
1. TECHNICAL 
a. Faulty aspiration – failure to insert the needle in to the tumour 
especially when the tumour in small and breast in large and 
fatty 
b. Blocking the needle with fat 
c. Local anaesthetic, if used, may dilute the specimen 
d. Faulty fixation and staining 
2. INTERPRETATION 
 For proper interpretation, adequate smear and expert 
cytopathologist are essential. 
Both the procedures was clearly explained to the patient and 
informed written consent was obtained.   The procedure was carried 
out in the treatment room of the ward and in the supine portion with 
the breast well exposed. 
In this study, for FNAC we used 24 gauge needle and for trucut, 
18 gauge needle. 
The FNAC sample was usually reported within 24 hrs by our 
pathologist, whereas for TCNB, it will take of about 72 hrs. 
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All the reports were read by a single pathologist and HPE report 
was also read by the same pathologist without revealing the FNAC 
and TCNB reports. 
CYTOLOGICAL REPORT 
According to UK National Health Science screening35 
programme.  Cytological report divided into following categories. 
1. Normal  tissue / inadequate sample 
2. Benign lesions – e.g.) Fibroadenoma / Fibrocystic disease 
3. Lesion of uncertain malignant potential (e.g.) sclerosing 
ductal lesions. Atypical ductal hyperplasia 
4. Suspicious of malignancy  
5. Malignant   
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OBSERVATION AND ANALYSIS 
 
Total number of patients in this study was 65.  Out of a total 65 
breast lump aspirations in 65 patients, final diagnosis was benign in 33 
breast lumps and malignant in 32 breast lumps. 
Analysis of results was done in benign and malignant disease 
separately. 
A. HISTORY 
1. AGE, SEX AND MARITAL STATUS 
 Out of 33 cases with benign breast 23 (56%) were married.  
Maximum incidence in this group was in 3rd decade (36%). 
Where as, in 32 malignant breast lumps all were married 
(100%) peak age incidence was in 4th decade (37%) 
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Table No. 3 
AGE, SEX AND MARITAL STATUS 
Marital Status 
Diagnosis 
No. of 
Cases Married Unmarried
Age in 
years 
No. of 
Cases 
Benign 33 23 10 11-20 
21-30 
31-40 
41-50 
51-60 
61-70 
7 
12 
8 
3 
3 
0 
Malignant 32 32 0 11-20 
21-30 
31-40 
41-50 
51-60 
61-70 
0 
3 
12 
6 
10 
1 
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2. DURATION OF LUMP 
 Among the benign breast lesions, peak group was less than 3 
months (19 cases out of 33) peak incidence of malignant lesions falls 
in the group for 4-6 months. 
 
Table No. 4 
DURATION OF LUMPS 
Diagnosis 
< 3 
months 
4 – 6 
months
7 – 9 
months
10 – 12 
months
> 1 yr Total 
Benign 19 7 5 2 0 33 
Malignant 11 12 6 2 1 32 
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3. MENSTRUAL STATUS 
Table No. 5 
MENSTRUAL STATUS  
 
Status of Menstruation 
Diagnosis No. of Cases 
Premenopausal Postmenopausal
Benign 33 28 5 
Malignant 32 17 15 
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B. EXAMINATION 
1. NIPPLE CHANGES OF MALIGNANCY 
 Out of 32 malignant lesions of breast 6 cases showed changes in 
the nipple suggestive of malignancy in the form of retraction.  In the 
series of benign lesions of 33 cases, no cases showed changes in the 
nipple. 
2. POSITION OF THE SWELLING IN BREAST 
 The following table was based on the occupancy of the lump 
either exclusively or  predominantly in relation to quadrants of breast. 
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Table No. 6 
SITE OF SWELLING 
Maximum incidence of benign breast lesions and malignant 
lesions were in upper inner quadrant. 
Site Benign Malignant 
Upper - Outer 6 6 
Upper – Inner 16 7 
Lower - Outer 8 3 
Lower – Inner 3 3 
Central 0 2 
All Quadrants 0 2 
Lower Inner & Central 0 2 
Upper Outer & Central 0 3 
Upper Inner & Central 0 1 
Upper Outer & Inner 0 3 
 33 32 
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3. SIZE OF SWELLING 
 
Table No. 7 
SIZE OF SWELLING 
Maximum incidence of benign and malignant breast lumps were 
3-5 cm in size. 
Size Benign Malignant 
< 2 cm 8 1 
3 – 5 cm 23 20 
6 – 10 cm 2 11 
> 10 cm 0 0 
 33 32 
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Table No. 8 
SHOWING CORRELATION BEWTEEN FNAC AND 
EXCISIONAL BIOPSY HISTOLOGY 
 
Sl. 
No. 
Excisional Biopsy 
Histology 
Correct 
Diagnosis
False 
Positive
False 
Negative Insufficient
1 Fibroadenoma (28) 27 (96%) - - 1 (4%) 
2 Ductal carcinoma (25) 22 (88%) - 3 (12%) - 
3 Chronic nonspecific 
mastitis (2) 
2 (100%) - - - 
4 Breast abcess (2) 2 (100%) - - - 
5 Mixed carcinoma 
(Both ductal and 
lobular) (1) 
0 - 1(100%) - 
6 Malignant phylloides 
tumour (1) 
1 (100%) - - - 
7 Benign Phylloides 
tumour (1) 
0 - 1(100%) - 
8 Invasive squamous 
cell carcinoma (1) 
0 - 1(100%) - 
9 Lobular carcinoma (2) 2 (100%) - - - 
10 Mucinous adeno 
carcinoma (1) 
1(100%) - - - 
11 Metaplastic  
carcinoma (1) 
1(100%) - -  
 Total 58 (89%) 0 6 (9%) 1 (2%) 
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Table No. 9 
SHOWING CORRELATION BEWTEEN TRUCUT BIOPSY 
AND HISTOPATHOLOGICAL EXAMINATION 
Trucut Biopsy Sl. 
No. 
Histological 
Diagnosis Correct Diagnosis 
False 
Positive
False 
Negative Insufficient
1 Fibroadenoma (28) 25 (89%) - - 3 (11%) 
2 Ductal carcinoma (25) 24 (96%) - - 1 (4%) 
3 Chronic nonspecific 
mastitis (2) 
2 (100%) - - - 
4 Breast abcess (2) 2 (100%) - - - 
5 Mixed carcinoma 
(Both ductal and 
lobular) (1) 
0 - 1(100%) - 
6 Malignant phylloides 
tumour (1) 
1 (100%) - - - 
7 Benign Phylloides 
tumour (1) 
0 - 1(100%) - 
8 Invasive squamous 
cell carcinoma (1) 
1 (100%) - 1(100%) - 
9 Lobular carcinoma (2) 2 (100%) - - - 
10 Mucinous adeno 
carcinoma (1) 
1 (100%) - - - 
11 Metaplastic  
carcinoma (1) 
1 (100%) - -  
 Total 59 (91%) 0 2 (3%) 4 (6%) 
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RESULTS 
 
FNAC gave correct diagnosis in 89%, while in 6 cases the result 
was false negative and in 1 case no opinion could be made.   
The sensitivity of FNAC is 90% and specificity is 100%.  The 
positive predictive value is 100% while negative predictive value is 
90%.  In 1 patient, unsatisfactory smear obtained, which was not taken 
for account for analysis. Overall accuracy of FNAC is 98% and that of 
TCNB is 97%. 
TCNB gave the correct diagnosis in 91%, 2 false negative cases 
with 4 cases the biopsy was inadequate to give any diagnosis.  The 
sensitivity and specificity of TCNB was 96% and 100% respectively.  
Similarly positive predictive value was 100% and 96% respectively.  
In 4 cases, inadequate material obtained. 
  75
DISCUSSION 
 
All agree on the necessity for prompt diagnosis of any breast 
lump.  Hence workers all over the world are in search of a method 
which can give an early as well as an accurate diagnosis.  The incision 
or excision biopsy in a well accepted diagnostic method for breast 
lump, but both procedures are traumatic and require operation theatre 
facilities.  In the recent years, much of emphasis is laid on FNAC42.  
Trucut needle is a simplified needle and needle biopsy can be 
performed in out patient services. 
FNAC is used extensively in the diagnosis of any lump.  The 
high rate of false negative diagnosis is early reports and seedling of 
the cells along the needle track were the reasons that thought.  Martin 
and Ellis introduced the technique in 1934, it was not well accepted.  
The visit of tumour dissemination has been shown to be more in 
surgical biopsy as compared to FNAC.  The false negative result in 
cancer of the breast is 0-10 %.  The present study had the same false 
negative rate. 
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The reason for false negative diagnosis is due to number of 
factors which include dense fibrosis of the tumour (failure to pierce 
the tumour) and erroneous interpretation. 
The correct diagnosis by FNAC5 can be achieved in 80-95% 
cases.  In the present series the correct diagnosis by FNAC in 89% 
cases.  There are many advantages of FNAC as it saves hospital 
admission, saves preliminary biopsy, saves frozen section and the 
patient known beforehand the type of operation. 
Further, it allows rationale planning of operation list and avoid 
unnecessary admissions.  It can be carried out as an out patient 
procedure with minimal trauma to the patient, can be repeated at ease 
and mentally prepares the patient and surgeon. 
Further, it provides and opportunity of follow up the patient 
with clinically benign lesions without surgery. 
In a busy out patient department and in busy operation list, the 
surgical biopsy is a time consuming process. So cutting needle biopsy 
provides an easier and time saving alternative. 
The vim Silvermann’s needle was first used in 1960 in 
diagnosis of the breast cancer.  An excisional biopsy has several 
disadvantages as it requires general anaesthesia and affects the choice 
of incision for definitive surgery.  TCNB34 is safe and simple 
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technique.  The patients acceptance is high and apart from mild 
brushing no complication has been encountered. 
On positive diagnosis of malignancy by TCNB4, a definitive 
surgery can be planned as no false positive results are reported by this 
techniques.  In the present study, there were 2 false negative cases and 
in 4 cases, the biopsy material, inadequate to give any diagnosis.  The 
success rate of needle biopsy depends upon the size and consistency of 
the lump and the type of needle used. 
In fatty obese patients, where the breast is bulky, the needle 
may miss the lesion.  The trucut needle has the advantages on the 
other needles as it quite handy, cuts a good core of tissue with least 
trauma to the patient. 
Both the technique have their own advantages and draw backs.  
FNAC11 is the most simple techniques and does not require any 
special instrument and the result can be obtained in a few hours time.  
FNAC is associated with false positive and false negative results and 
because of this, still it is controversial to decide the final surgery based 
only on the results of FNAC. 
The result of FNAC19 should be correlated with the clinical 
impression.  TCNB is a histological diagnosis while FNAC is 
cytological diagnosis where one has to report on few cells.  As there 
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are no false positive results with TCNB so once a diagnosis of 
malignancy is established.  One can go for the definitive surgery.  
TCNB44 is comparatively more traumatic than FNAC as it may 
sometime bruise the breast. 
On comparing the results of both techniques, it was found that 
in benign, correct diagnosis was maximum of FNAC (94%) and 
TCNB (88%), while in malignancy by FNAC and TCNB correct 
diagnosis was 84% and 94% respectively.  Taking all the techniques 
together, diagnosis could be reached in 90% of cases.   
COMPARISON OF STUDY 
Table No. 10 
FNAC TCNB 
Studies 
No. 
of 
cases 
Sen Spe Acc 
P 
Value
Sen Spe Acc 
P 
Value 
NS Yong 
(Singapore 
Medical 
College) 
 
39 
 
84 
to 
97.5
 
99 to 
100 
 
90 
 
<0.02
 
90 
 
100 
 
67 
 
<0.02 
Present study 65 90 100 98 0.016 96 100 97 0.031 
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The accuracy of FNAC and TCNB are 98% and 97% 
respectively.  The difference beings statistically significant with a  
p<0.02.  P value of FNAC and TCNB are 0.016 and 0.031 
respectively, using McNemar test for paired data, which shows both 
the tests are significant with FNAC most significant compared to 
TCNB. 
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CONCLUSION 
 
This study has helped to correlate cytological report, trucut  
needle biopsy and histopathology.  Further out patient assessment of 
breast lumps was done for the period of 2005 – 2006 in our hospital. 
The results of this study showed almost equal detection rates by 
FNAC (89%) and trucut biopsy (91%) when comparing with 
histopathological examination.  Trucut biopsy29, however was able to 
give a histological diagnosis and results correlated 100% with the final 
histology.  However, in the setting of an out patient clinic, we would 
like to recommend the use of FNAC for the diagnosis of suspicions 
breast lumps.  With the results we would be able to advise the patient 
and recommend further treatment.  However there is need for an 
excision biopsy to obtain a definitive histology before proceeding to 
definitive surgery as more have been cases of false positive results for 
FNAC. 
Considering both techniques, it can be concluded that if 
FNAC37 can find a diagnosis one can go ahead with a definitive 
operation. But, if in a clinically suspected case, FNAC is negative then 
one should go for further investigation.  In this concern the TCNB is 
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ideal for getting the histological report.  Even if TCNB report comes 
out to be negative, one should proceed with excisional or incisional 
biopsy and according histopathological report, patient can be planned 
for further treatment (surgery). 
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PROFORMA 
Case No  :  
Name  : 
Age  : 
IP No  : 
Ward  : 
Unit  :  
Duration : 
Complaints : 
Presenting illness  : Unilateral / Bilateral  
Pain    : Yes / No 
Discharge  : Yes / No – Serous / Blood / Green 
Lump   : Yes / No 
Personal History : 
Married / Unmarried : 
Menarche   : 
No. of Children  : 
Breast Fed   : 
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Breast Examination : 
Nipple & Areola  : Normal / Raised  
  Prominent / Flattened / Retracted  
  Fissure / Crack / Eczema  
Skin over the Breast : Normal / Dimpling /  
     Retraction / Puckering  
Sweeling : 
Location  : 
Size  : 
Shape  : 
Surface : 
Margin : 
Consistency : 
Fixity  : 
Provisional Diagnosis : 
FNAC  : 
Trucut Needle Biopsy : 
Excision Biopsy  : 
Final Diagnosis  : 
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CONSENT FORM 
Patient Name : 
Age / Sex  : 
IP No.  : 
Unit / Ward  : 
Diagnosis  : 
As I have lump in the breast, I am willing to undergo for tissue 
biopsy by FNAC and trucut biopsy. 
 
Patient’s Signature 
 
Xg;g[jy; gotk; 
nehahspapd; bgah; : 
taJ / ghypdk;  : 
kUj;Jtkid vz; : 
a{dpl; / thh;L  : 
nehahspapd; tpguk; : 
 vdJ khh;gfj;jpy; fl;o cs;sjhy;/ mjid Crp \yk; rij ghpl;ir bra;J 
bfhs;s rk;kjpf;fpnwd; (FNAC & Trucut Biopsy). 
 
  92
nehahspapd; ifbaGj;J 
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MASTER CHART 
 
Sl. 
No. Name Age 
Unit / 
Ward 
Inpatient 
Number Period 
Lump 
Location 
Lump 
Size FNAC Trucut Biopsy Excision Biopsy Final Diagnosis Procedure 
1 Kaveri 36 FSIII/SV 3741 Jan 
2005 
® lower outer 5x4 Ductal Ca Ductal Ca Invasive ductal 
ca 
® Ca breast ® MRM 
2 Nagamani 20 FSII/SI 3360 Jan 
2005 
(L) upper 
inner 
2x2 Fibro adenoma Fibro adenoma  Fibro adenoma 
pericanalicular  
(L) Fibro 
adenoma breast 
® Excision 
3 Dhanalakshmi 25 FSII/SIII 7631 Jan 
2005 
(L) lower 
inner 
3x4 Fibro 
adenomatoid 
hyperplasia  
Fibro adenoma Fibro adenoma – 
intracanalicular 
(L) Fibro 
adenoma breast 
Excision 
4 Anushiya 40 FSII/SIII 2928 Feb 
2005 
® upper inner 4x3 Ductal Ca Ductal Ca Mixed Ca – both 
ductal and 
lobular Ca 
® Ca breast ® MRM 
5 Kamalathal 60 FSII/SIII 5475 Feb 
2005 
® upper outer 5x6 Ductal Ca Ductal Ca Invasive Ductal 
ca  
® Ca breast ® MRM 
6 Sarojini 35 FSII/SIII 3006 Feb 
2005 
® upper outer 4x3 Ductal Ca Ductal Ca Invasive Ductal 
ca 
® Ca breast ® MRM 
7 Vijaya 37 FSII/SII 4217 Feb 
2005 
(L) upper 
inner 
3x2 Fibro adenoma Fibro adenoma Fibro adenoma 
pericanalicular 
(L) Fibro 
adenoma breast 
(L) Excision 
8 Maragatham 23 FSIII/SV 9007 Mar 
2005 
® upper inner 3x2 Inadequate 
kindly rpt 
Fibro adenoma Fibro adenoma 
pericanalicular 
® Fibro adenoma 
breast 
® Excision 
9 Syamala 40 FSIII/SIV 9961 Mar 
2005 
(L) upper 
inner 
4x4 Ductal Ca Ductal Ca Ductal ca (L) Ca breast (L) MRM 
10 Renuka 38 FSIII/SV 9977 Mar 
2005 
® upper inner 4x4 Ductal Ca Ductal Ca Ductal ca ® Ca breast ® MRM 
11 Karupathal 55 FSIII/SIV 10867 Mar 
2005 
® lower 
inner, central 
5x6 Ductal Ca Ductal Ca Ductal ca ® Ca breast ® MRM 
12 Chellammal 35 FSIII/SIV 10684 Mar 
2005 
® lower outer 3x2 Fibro adenoma Fibro adenoma Fibro adenoma 
pericanalicular 
® Fibro adenoma 
breast 
® Excision 
13 Kamalam 23 FSIII/SIV 10553 Mar 
2005 
® upper inner 2x3 Fibro adenoma Fibro adenoma Fibro adenoma 
pericanalicular 
® Fibro adenoma 
breast 
® Excision 
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Sl. 
No. Name Age 
Unit / 
Ward 
Inpatient 
Number Period 
Lump 
Location 
Lump 
Size FNAC Trucut Biopsy Excision Biopsy Final Diagnosis Procedure 
14 Chithra 29 FSIII/SV 11792/05 Mar 
2005 
® lower outer 6x5 Fibrocystic 
changes 
Fibro cystic 
changes  
Fibrocystic 
disease with 
chronic mastitis  
® Fibrocystic 
disease with 
mastitis  
® Excision 
15 Eswari 25 FSIII/SIV 11240 Mar 
2005 
(L) upper 
outer 
3x4 Fibro adenoma Ductal carcinoma Ductal 
carcinoma 
(L) Ca breast (L) MRM 
16 Velathal 45 FSIII/SIV 12188 Mar 
2005 
® lower inner 4x6 Ductal ca Ductal ca Invasive ductal 
carcinoma 
® Ca breast ® MRM 
17 Kullayee 50 FSIII/SIV 12186 Mar 
2005 
All quadrants 8x8 Phyllodes tumour Phyllodes tumour Phyllodes 
tumour – low 
grade 
sarcomatous 
transformation  
(L) malignant 
phylloides 
tumour 
(L) MRM 
18 Preethamercy 23 FSIII/SIV 20347 Apr  
2005 
(L) lower 
outer 
1x1 Fibro adenoma Fibro adenoma Fibroadenoma 
pericanalicular 
type 
(L) fibro 
adenoma 
(L) Excision 
19 Rajalakshmi 19 FSIII/SIII 16574 Apr  
2005 
® lower inner 2x2 Fibro adenoma Fibro adenoma Fibroadenoma 
pericanalicular 
type 
® fibro adenoma ® Excision 
20 Balkies 55 FSIII/SIV 16960 Apr  
2005 
(L) upper 
inner 
5x4 Ductal carcinoma Invasive ductal 
carcinoma 
Invasive ductal 
carcinoma 
(L) Ca breast (L) MRM 
21 Vanjiyammal 60 FSIII/SIV 17600 Apr  
2005 
® upper 
outer, central 
6x4 Ductal carcinoma Ductal carcinoma Invasive ductal 
carcinoma 
® Ca breast ® MRM 
22 Ambiga 20 FSIII/SIV 17577 Apr  
2005 
® upper inner 3x3 Fibro adenoma Fibro adenoma Fibro adenoma 
intra canalicular  
® fibro adenoma ® Excision 
23 Arammal 50 FSIII/SIV 27355 May 
2005 
® upper 
inner, central 
5x4 Atypical cells Ductal carcinoma Invasive ductal 
carcinoma 
® Ca breast ® MRM 
24 Suganthi 35 FSIII/SV 26285 May 
2005 
Central 
quadrant 
5x4 Ductal ca Ductal carcinoma Invasive ductal 
carcinoma 
® Ca breast ® MRM 
25 Jothimani 55 FSIII/SIV 31722 June  
2005 
(L) upper 
outer 
2x2 Fibroadenoma / 
fibroadenomatoid 
hyperplasia 
Fibroadenoma / 
fibroadenomatoid 
hyperplasia 
Fibro adenoma 
mixed type 
(L) fibro 
adenoma 
(L) Excision 
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Sl. 
No. Name Age 
Unit / 
Ward 
Inpatient 
Number Period 
Lump 
Location 
Lump 
Size FNAC Trucut Biopsy Excision Biopsy Final Diagnosis Procedure 
26 Gomathi 25 FSIII/SIV 34821 June  
2005 
(L) upper 
inner 
3x2 Fibro adenoma Inadequate Fibroadenoma 
pericanalicular 
type 
(L) fibro 
adenoma 
(L) Excision 
27 Nagarathinam 46 FSIII/SIV 31280 June  
2005 
(L) upper 
inner 
2x3 Fibro adenosis Fibrocystic 
disease 
Fibrocystic 
disease 
(L) fibro 
adenoma 
(L) Excision 
28 Kaliammal 55 FSIII/SIV 38548 June  
2005 
(L) upper 
outer, inner 
5x6 Atypical cells Ductal ca Invasive ductal 
ca 
(L) Ca breast (L) MRM 
29 Asma Begum 22 FSIII/SIV 37567 June  
2005 
® upper inner 
(O) upper 
outer 
2x1 
 
2x2 
 
B/L fibro 
adenoma 
B/L 
fibroadenoma 
B/L 
fibroadenoma 
perinalicular 
type 
B/L 
fibroadenoma 
Excision  
30 Saraswathy 30 FSIII/SIV 38798 June  
2005 
® central 3x2 Ductal carcinoma Invasive 
squamous cells 
ca 
Invasive 
squamous cell ca 
® Ca breast 
recurrent 
® recurrent 
nodule 
excision 
31 Parvathy 35 FSIII/SIV 37891 June  
2005 
(L) upper 
inner 
3x4 Fibro adenoma Fibro adenoma Fibro adenoma 
intracanalicular 
tupe 
(L) fibro 
adenoma 
Excision 
32 Palaniammal 40 FSIII/SIV 38469 June  
2005 
® upper 
outer, central 
5x6 Ductal carcinoma Ductal carcinoma Invasive ductal 
ca 
® Ca breast ® MRM 
33 Mymoon 57 FSIII/SIV 36885 July 
2005 
® lower  
inner and  
(L) central 
2x2 
 
3x4 
® Atypical cells 
(L) Inadequate 
® lobular  ca 
(L) lobular ca 
B/L lobular ca (L) recurrent ca 
breast and ® ca 
breast 
(L) recurrent 
nodule 
excision and 
® MRM 
34 Shanthi 36 FSIII/SIV 34067 July 
2005 
(L) upper 
inner  
2x2 Inadequate Fibro adenoma Fibroadenoma 
perinalicular 
type 
(L) fibro 
adenoma 
Excision 
35 Subbulakshmi 30 FSIII/SIV 36738 July 
2005 
® lower inner 4x3 Ductal carcinoma Ductal carcinoma Invasive ductal 
ca 
® ca breast ® MRM 
36 Indira 34 FSIII/SIII 32247 July 
2005 
(L) lower 
outer 
4x3 Fibro adenoma Fibro adenoma Fibro adenoma 
mixed 
(L) fibro 
adenoma 
 
Excision 
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Sl. 
No. Name Age 
Unit / 
Ward 
Inpatient 
Number Period 
Lump 
Location 
Lump 
Size FNAC Trucut Biopsy Excision Biopsy Final Diagnosis Procedure 
37 Ammaniyammal 55 FSIII/SIV 35140 July 
2005 
All quadrants 8x6 Ductal carcinoma Invasive ductal 
carcinoma 
Infiltrating 
ductal ca 
(L) Ca breast (L) MRM 
38 Subaitha 55 FSIII/SIV 36754 July 
2005 
® upper inner 5x6 Infiltrating ductal 
carcinoma 
Invasive ductal 
carcinoma 
Infiltrating 
ductal ca 
® Ca breast ® MRM 
39 Muniamma 42 FSIII/SIV 36711 July 
2005 
® lower outer 4x5 Ductal carcinoma Mature 
apipocytes thin 
fibrous septa 
Invasive ductal 
ca 
® Ca breast ® MRM 
40 Ramija 32 FSIII/SIV 36712 July 
2005 
(L) upper 
outer 
6x6 Fibro adenoma Fibrosis and 
cystic dilatation 
of ductules 
fibroadenoma 
perinalicular 
with fibrocystic 
change 
(L) fibroadenoma 
and fibroystic 
disease 
(L) Excision  
41 Malliga 34 FSIII/SIV 34618 July 
2005 
(L) upper 
inner 
3x2 Atypical cells Abundant 
mucinous 
material 
Mucinous adeno 
carcinoma  
(L) Ca breast (L) MRM 
42 Nazeera 19 FSIII/SIV 36748 July 
2005 
® upper ouer 5x5 Fibro adenoma Fibro adenoma 
breast 
Fibro adenoma 
mixed 
® fibro adenoma ® Excision 
43 Karupathal 21 FSIII/SIII 32368 July 
2005 
® upper outer 5x3 Fibro adenoma Fibro adenoma Fibro adenoma 
mixed 
® fibro adenoma ® Excision  
44 Dhanalakshmi 49 FSIII/SIV 38720 Aug 
2005 
® lower outer 2x3 Abcess Inadequate Abcess ® breast abcess I & D 
45 Joy 31 FSIII/SIV 38785 Aug 
2005 
(L) upper 
outer, inner 
6x5 Ductal ca Ductal ca Invasive ductal 
ca 
(L) Ca breast  (L) MRM 
46 Angathal 55 FSIII/SIV 33888 Aug 
2005 
® upper inner 4x4 Fibrocystic 
disease 
Fibrocystic 
disease 
Phylloides 
tumour – benign 
® Benign 
phylloides 
tumour 
® Excision 
47 Roja 35 FSIII/SIII 32748 Aug 
2005 
® upper outer 3x2 Atypical cells Lobular ca Lobular ca ® Ca breast ® MRM 
48 Chandra 58 FSIII/SIV 36731 Aug 
2005 
® Central, 
upper, outer 
5x4 Atypical cells Ductal carcinoma Invasive ductal 
ca 
Recurrent Ca 
breast 
® recurrent 
nodule 
excision 
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Sl. 
No. Name Age 
Unit / 
Ward 
Inpatient 
Number Period 
Lump 
Location 
Lump 
Size FNAC Trucut Biopsy Excision Biopsy Final Diagnosis Procedure 
49 Kamala 20 FSIII/SV 32087 Sep  
2005 
® upper inner 2x1 Fibro adenoma Fibro adenoma Fibro adenoma 
pericanalicular 
type 
® fibro adenoma (L) Excision  
50 Lakshmiammal 60 FSIII/SIV 32067 Sep  
2005 
(L) lower 
inner 
2x2 Ductal carcinoma Ductal carcinoma Invasive ductal 
ca 
(L) Recurrent Ca 
breast 
(L) Excision 
51 Solaiyammal 65 FSIII/SIV 46587 Sep  
2005 
(L) upper 
outer,  inner 
5x6 Ductal carcinoma Ductal carcinoma Invasive ductal 
ca 
(L) Ca breast (L) MRM 
52 Gunalakshmi 50 FSIII/SIV 54662 Oct 
2005 
(L) lower 
outer 
5x4 Fibro 
adenomatoid 
hyperplasia 
Fibrocystic 
disease 
Fibrocystic 
disease of breast 
(L) fibro cystic 
disease 
(L) Excision 
53 Paruleshanishia 18 FSIII/SIV 58925 Oct 
2005 
® upper inner 2x3 Fibro adenoma Thin strip of 
fibrous tissue 
only 
Fibro adenoma 
pericanalicular 
type 
® fibro adenoma ® Excision 
54 Thoulathnisha 18 FSIII/SIV 58993 Nov  
2005 
® lower outer 2x2 Fibro adenoma Fibro adenoma Fibro adenoma 
intranalicular 
type 
® fibro adenoma ® Excision 
55 Mani 39 FSIII/SIV 53029 Nov  
2005 
® upper outer 3x2 Fibro 
adenomatoid 
hyperplasia 
Ductal carcinoma Invasive ductal 
ca 
® ca breast   ® MRM 
56 Saroja 43 FSIII/SIV 63892 Dec 
2005 
(L) upper 
inner 
4x5 A typical cells Squamous cell ca Metaplastic ca (L) Meta plastic 
ca breast 
(L) MRM 
57 Rajammal 40 FSIII/SIV 64787 Dec 
2005 
® upper inner 4x4 Fibrous tissue 
proliferation with 
lymphoid 
aggregates 
Chronic 
nonspecific 
mastitis 
Chronic 
nonspecific 
mastitis 
® Chronic 
nonspecific 
mastitis 
Conservative 
treatment  
58 Kaliayammal 55 FSIII/SIII 66568 Dec 
2005 
(L) lower 
outer 
3x2 Abcess Mastitis with 
necrotic material 
Suggestive of 
abcess 
(L) breast abcess I & D 
59 Amaravathy 24 FSIII/SIV 65798 Dec 
2005 
® upper inner 2x3 Fibro adenoma Inadequate 
specimen 
Fibro adenoma 
intracanalicular 
® fibro adenoma Excision 
60 Tamilarasi 38 FSIII/SIV 63972 Dec 
2005 
(L) lower 
outer 
3x2 Atypical cells Ductal ca Invasive ductal 
ca 
(L) Ca breast (L) MRM 
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Sl. 
No. Name Age 
Unit / 
Ward 
Inpatient 
Number Period 
Lump 
Location 
Lump 
Size FNAC Trucut Biopsy Excision Biopsy Final Diagnosis Procedure 
61 Jayamani 37 FSIII/SIV 9774 Jan 
2006 
(L) upper 
outer 
2x3 Fibro adenoma Fibro adenoma Fibro adenoma 
intracanalicular 
(L) Fibro 
adenoma 
(L) Excision 
62 Sangeetha Mary 21 FSIII/SV 9146 Jan 
2006 
® upper inner 2x3 Fibro adenoma Fibro adenoma Fibro adenoma 
perinalicular 
 
®  Fibro adenoma ® excision 
63 Sumithra 21 FSIII/SIV 9889 Jan 
2006 
® lower inner 2x3 Fibro adenoma Fibro adenoma Fibro adenoma – 
mixed 
®  Fibro adenoma ® excision 
64 Vijaya 30 FSIII/SIII 9558 Jan 
2006 
® upper inner 2x3 Fibrocystic 
disease with 
atypical cells 
Fibro adenoma Fibro adenoma 
perinalicular 
(L) Fibro 
adenoma 
(L) Excision 
65 Patchiyammal 45 FSIII/SVI 4555 Jan 
2006 
® upper outer 4x2 Ductal ca Ductal ca Invasive ductal 
ca 
® Ca Breast ® MRM 
 
 
 
 
